Aquatic Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-88,900
| Closed | -$10.2M | – | 1524 |
|
|
2024
Q3 | $10.2M | Buy |
88,900
+64,100
| +258% | +$7.39M | 0.27% | 99 |
|
|
2024
Q2 | $3.41M | Buy |
+24,800
| New | +$3.41M | 0.13% | 167 |
|
|
2023
Q2 | – | Sell |
-600
| Closed | -$61K | – | 1613 |
|
|
2023
Q1 | $61K | Buy |
+600
| New | +$61K | ﹤0.01% | 849 |
|
|
2022
Q4 | – | Sell |
-27,100
| Closed | -$2.88M | – | 1660 |
|
|
2022
Q3 | $2.88M | Buy |
27,100
+24,500
| +942% | +$2.6M | 0.28% | 89 |
|
|
2022
Q2 | $253K | Buy |
+2,600
| New | +$253K | 0.08% | 284 |
|